Skip to main content

Animations

MJFF Publications

4181 - 4190 of 8684 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    RESTRICTED
    Title: Concerns with the new biological research criteria for synucleinopathy
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00213-8
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: VAMP2 chaperones α-synuclein in synaptic vesicle co-condensates
    Journal Name: Nature Cell Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41556-024-01456-1
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Prevalence of neuromyelitis optica spectrum disorder in the United States
    Journal Name: Multiple Sclerosis Journal
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/13524585231224683
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Rapid frontotemporal gray matter loss in proposed body-first Parkinson’s disease: a longitudinal voxel-based morphometry study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2025.1579561
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Opportunities and Limitations of Wrist-Worn Devices for Dyskinesia Detection in Parkinson’s Disease
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s25144514
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Discovery of N-(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson’s Disease with Positron Emission Tomography
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells14141108
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Thalamic and Visual Network Dysfunction Relates to Tremor Response in Thalamic Deep Brain Stimulation
    Journal Name: Tremor and Other Hyperkinetic Movements
    Publisher: Ubiquity Press, Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.5334/tohm.1039
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Protocol for CRISPR-based manipulation and visualization of endogenous α-synuclein in cultured mouse hippocampal neurons
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2025.103945
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-62458-7
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01060-6
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.